Clinical Research Directory
Browse clinical research sites, groups, and studies.
Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers
Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Summary
Use Dapagliflozin 10 mg, Saxagliptin 5 mg, Metformin 500 mg treat type 2 diabetes patients with controlled cancers
Key Details
Gender
All
Age Range
24 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2025-06-15
Completion Date
2026-11-28
Last Updated
2025-07-11
Healthy Volunteers
No
Conditions
Interventions
Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
Farxiga® (dapagliflozin) 10 mg, Onglyza® (saxagliptin) 5 mg, Metformin 500 mg, Oral Mix Prescription Treat type 2 diabetes patients with controlled cancers
China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
China Import (dapagliflozin) 10 mg, China Import (saxagliptin) 5 mg, Metformin 500 mg, Oral Mix Prescription Treat type 2 diabetes patients with controlled cancers
Locations (1)
Medicine Invention Design, Inc. - IORG0007849 - NPI-1023387701
Rockville, Maryland, United States